Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet

Vol. 45 (1): 5-9, January – February, 2019

doi: 10.1590/S1677-5538.IBJU.2018.0734


EDITORIAL

Antonio Cassio Assis Pellizzon 1
1 Departamento de Radioterapia, Hospital AC Camargo Cancer Center, São Paulo, Brasil

Prostate cancer is still the most frequently diagnosed cancer in American men despite a 7.6% decrease in cancer incidence between 2011 and 2014 (1). In Brazil, about 68,220 men are expected to be diagnosed with prostate cancer in 2018 (2).

[Read more]


print

Related Post